Back
Aptevo Therapeutics Stock Price Chart
Sponsored
APVO
Sponsored
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
14
APVO
Aptevo Therapeutics
Last Price:
4.10
Seasonality Move:
-34.13%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing selling pressure, which indicates risk of future bearish movement.
Aptevo Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.45 | Sell |
20-day SMA: | 9.45 | Sell |
50-day SMA: | 8.87 | Sell |
200-day SMA: | 38.37 | Sell |
8-day EMA: | 7.76 | Sell |
20-day EMA: | 8.92 | Sell |
50-day EMA: | 9.67 | Sell |
200-day EMA: | 177.43 | Sell |
Aptevo Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.69 | Sell |
Relative Strength Index (14 RSI): | 32.79 | Sell |
Chaikin Money Flow: | -796984 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.69 - 11.35) | Sell |
Bollinger Bands (100): | (7.17 - 13.87) | Sell |
Aptevo Therapeutics Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aptevo Therapeutics Stock
Is Aptevo Therapeutics Stock a Buy?
- Aptevo Therapeutics share price is 4.09 while APVO 8-day simple moving average is 8.45, which is a Sell signal.
- The stock price of APVO is 4.09 while Aptevo Therapeutics 20-day SMA is 9.45, which makes it a Sell.
- Aptevo Therapeutics 50-day simple moving average is 8.87 while APVO share price is 4.09, making it a Sell technically.
- APVO stock price is 4.09 and Aptevo Therapeutics 200-day simple moving average is 38.37, creating a Sell signal.
APVO Technical Analysis vs Fundamental Analysis
Sell
14
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy or a Sell?
-
Aptevo Therapeutics stock is rated a Sell
The current Aptevo Therapeutics [APVO] share price is $4.09. The Score for APVO is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Aptevo Therapeutics Stock Info
Market Cap:
2.05M
Price in USD:
4.09
Share Volume:
805.6K
Aptevo Therapeutics 52-Week Range
52-Week High:
399.60
52-Week Low:
4.08
Sell
14
Aptevo Therapeutics (APVO)
is a Sell
Aptevo Therapeutics Share Price Forecast
-
What is the Aptevo Therapeutics stock price today?
The Aptevo Therapeutics stock price is 4.09 USD today. -
Will APVO stock go up or go down?
Aptevo Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aptevo Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aptevo Therapeutics is overvalued.
Is Aptevo Therapeutics Stock a Buy?
- Aptevo Therapeutics share price is 4.09 while APVO 8-day exponential moving average is 7.76, which is a Sell signal.
- The stock price of APVO is 4.09 while Aptevo Therapeutics 20-day EMA is 8.92, which makes it a Sell.
- Aptevo Therapeutics 50-day exponential moving average is 9.67 while APVO share price is 4.09, making it a Sell technically.
- APVO stock price is 4.09 and Aptevo Therapeutics 200-day simple moving average is 177.43, creating a Sell signal.
Fundamental Analysis of Aptevo Therapeutics
Is Aptevo Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $11.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,519.81 per share, and an increase next year of $64.38 per share.
Technical Analysis of Aptevo Therapeutics
Should I short Aptevo Therapeutics stock?
- APVO Moving Average Covergence Divergence (MACD) indicator is -0.69, suggesting Aptevo Therapeutics is a Sell
- Aptevo Therapeutics Relative Strength Index (RSI) is 32.79, which suggest Aptevo Therapeutics is oversold
- The Bollinger Bands (25) for Aptevo Therapeutics is (7.69 - 11.35), which suggest Aptevo Therapeutics is a Sell
- The Bollinger Bands (100) for Aptevo Therapeutics is (7.17 - 13.87), which suggest Aptevo Therapeutics is a Sell
* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.